Close Menu

cloud computing

Genomic data analytics firm Sentieon uses the challenges to prove and increase customer confidence in its bioinformatics technology.

Researchers from startup Duality Technologies and Dana-Farber have demonstrated the efficacy and speed of a highly secure technique for analyzing encrypted genomic data.

The test detects SARS-CoV-2 from nasopharyngeal swab specimens and runs on standard qPCR instruments, including Thermo Fisher's Applied Biosystems 7500 Fast machine.

Regeneron Pharmaceuticals is among the new investors, as the bioinformatics company continues to scale up its multiomics platform to meet growing demand.

Fresh off a new investment round, the British firm seeks to help research labs and biopharma companies manage population-level genomics research.

The companies are making three COVID-19 tools available immediately for early access, with plans to add other nCounter software and potentially develop new products.

The funding will support the firm's international market expansion on the heels of the release of Lifebit CloudOS version 2.0 this week. 

In addition to developing standards for proteomics, metabolomics, and other kinds of data, DNAnexus will develop tools to help reviewers quickly and easily assess analysis pipelines.

Hitachi and Centre Léon Bérard have opened a research lab in Lyon that will apply AI to medical imaging and predict response to radiation therapy from genomic markers.

By participating in the project, the company, located in Tokyo, hopes to improve its cloud-based data management services while winning over new customers.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.